Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/37357
Title: | Juvenile idiopathic arthritis in a center in the western anatolia region in turkey | Other Titles: | Türkiye İç Batı Anadolu Bölgesi’ndeki bir merkezde jüvenil idiyopatik artrit | Authors: | Yener, G.O. Tekin, Z.E. Girişgen, İlknur Çetin, Ebru Nevin Akdağ, B. Yüksel, Selçuk |
Keywords: | Antirheumatic drugs Juvenile idiopathic arthritis Methotrexate adult ankylosing spondylitis Article child DAS28 disease activity erythrocyte sedimentation rate female follow up gene mutation human juvenile rheumatoid arthritis lymphadenopathy macrophage activation syndrome major clinical study male nuclear magnetic resonance imaging prospective study psoriatic arthritis sacroiliitis single nucleotide polymorphism splenomegaly spondyloarthropathy Turkey (republic) uveitis visual analog scale |
Publisher: | Kare Publishing | Abstract: | Aim: To demonstrate the demographic data, subgroup distributions, responses to treatment and outcomes of long-term follow-up in patients who were followed up and treated in our clinics with a diagnosis of juvenile idiopathic arthritis, and to compare these data with national and international data. Material and Methods: The files of 116 patients who had been diagnosed as having juvenile idiopathic arthritis, were initiated on treatment and presented for regular follow-up visits between January 2012 and January 2018, were examined. Their demographic findings, treatments, active/inactive disease states (on-medication and off-medication) and treatment response states were evaluated. Results: According to the International League of Associations for Rheumatology criteria, the subtypes were specified as enthesitis-related arthritis (n=38), oligoarticular (n=37), rheumatoid factor (-) polyarticular (n=17), systemic (n=15), rheumatoid factor (+) polyarticular (n=5), and psoriatic juvenile idiopathic arthritis (n=4). In total, the female/male ratio was found to be 1.5. The mean delay time between the first complaint and the diagnosis was found to be 5.7±5.2 months. The patients with systemic type were diagnosed at the earliest, while the patients with polyarticular and enthesitis-related subtypes were diagnosed at the latest. Thirty-two percent of the patients were treated with methotrexate alone, and 38% were given additional biologic drugs. In both treatment groups, the time to achieve inactive disease was the shortest in the oligoarticular group and the longest in the enthesitis-related arthritis group. In the study period, 38 patients were in remission off-medication (the highest rate (53.3%) was observed in the systemic group) and 71 patients were in remission on-medication (the highest rate (70.2%) was observed in the oligoarticular group). Remission was obtained in 94% of the patients. Conclusion: Enthesitis which is the remarkable finding of enthesitis-related arthritis, should not be overlooked in routine physical examination. Awareness of enthesitis can contribute to the prevention of diagnostic delay in children with enthesitis-related arthritis. ©Copyright 2020 by Turkish Pediatric Association-Available online at www.turkpediatriarsivi.com. | URI: | https://hdl.handle.net/11499/37357 https://doi.org/10.14744/TurkPediatriArs.2019.69320 |
ISSN: | 1306-0015 |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu TR Dizin İndeksli Yayınlar Koleksiyonu / TR Dizin Indexed Publications Collection WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Files in This Item:
File | Size | Format | |
---|---|---|---|
TPA-55-157.pdf | 193.63 kB | Adobe PDF | View/Open |
CORE Recommender
SCOPUSTM
Citations
5
checked on Nov 16, 2024
WEB OF SCIENCETM
Citations
7
checked on Nov 21, 2024
Page view(s)
100
checked on Aug 24, 2024
Download(s)
18
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.